The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

11 Jul 2018 10:38

RNS Number : 3108U
Adamas Finance Asia Limited
11 July 2018
 

ADAMAS FINANCE ASIA LIMITED

 

RESULT OF GENERAL MEETING

APPROVAL OF DISPOSAL OF GLOBAL PHARM INTEREST

 

Further to the announcement on 15 June 2018 in relation to the proposed disposal of the interest in Global Pharm, the Company is pleased to announce that the resolutions proposed at the General Meeting held earlier today were duly passed and that the Disposal has thereby been approved.

Completion of the Disposal and the associated issue of 17,746,479 new Ordinary Shares at a price of US$0.71 per share to Fortune Insight Limited will take place in due course.

A further announcement will be made when appropriate.

Capitalised terms used in this announcement have the meaning given to them in the announcement of 15 June 2018.

 

Enquiries:

Adamas Finance Asia Limited

John Croft

 

+44 (0)1825 830587

Nominated Adviser

 

WH Ireland Limited

Tim Feather

James Sinclair-Ford

+44 (0) 113 394 6600

Broker

 

Shard Capital Partners LLP

 

Philip Pooley

 

 

+44 (0) 20 7186 9967

Public Relations Advisers

 

Buchanan

Charles Ryland

Henry Wilson

+44 (0) 20 7466 5000

 

 About Adamas Finance Asia ("ADAM")

ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments. It aims to provide uncorrelated returns through a combination of capital growth and dividend income from a broad spectrum of national geographies and asset classes.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMKFLBFVDFXBBQ
Date   Source Headline
17th Mar 201511:00 amRNSWarrant Exercise Price - Correction
10th Mar 20153:02 pmRNSIssue of Equity
2nd Mar 20157:00 amRNSAdamas Named Best Asia Pacific Lender
18th Dec 20149:28 amRNSDisposal Of Interest In Global Pharm Holdings
29th Oct 20147:00 amRNSADAMAS Wins AICFC PE Credit Fund Of The Year Award
23rd Oct 20147:00 amRNSBRJ Fund exits Project Innovation
8th Oct 20147:00 amRNSGreater China Credit Fund
29th Sep 20147:00 amRNSKey Adviser Appointments by Investment Manager
24th Sep 20147:00 amRNSHalf Yearly Report
14th Aug 20147:00 amRNSBRJ Fund Exit and New Investments
6th Aug 20141:31 pmRNSAIM Disclosure Update
18th Jul 20147:00 amRNSAppointment of Joint Broker
14th Jul 20143:55 pmRNSResult of AGM
10th Jul 201411:48 amRNSUpdate to Issue of Equity
4th Jul 20147:00 amRNSFurther Investment in BRJ China Credit Fund
27th Jun 20147:00 amRNSChina's Cross-Border Funding Reforms
19th Jun 20142:02 pmRNSOffer to Warrantholders, Share Consolidation etc
17th Jun 201410:26 amRNSLoan to Portfolio Company
6th Jun 20147:00 amRNSFinal Results
30th May 201411:48 amRNSIssue of Equity
28th May 20147:00 amRNSExit by BRJ China Credit Fund Limited
20th May 20141:31 pmRNSAdamas Wins Three ACQ Global Awards
14th May 20147:00 amRNSChange of Adviser
29th Apr 20147:00 amRNSBRJ China Credit Fund Exit
9th Apr 20147:00 amRNSInvestment in BRJ China Credit Fund Limited
1st Apr 20147:00 amRNSDividend Distribution by Greater China Credit Fund
17th Mar 20147:00 amRNSPrivate Debt Investor Awards
24th Feb 20144:40 pmRNSSecond Price Monitoring Extn
24th Feb 20144:35 pmRNSPrice Monitoring Extension
21st Feb 20144:40 pmRNSSecond Price Monitoring Extn
21st Feb 20144:35 pmRNSPrice Monitoring Extension
20th Feb 20143:21 pmRNSChanges of Name, TIDM and ISIN
18th Feb 20145:14 pmRNSCompletion of Registration and Admission
18th Feb 20149:55 amRNSResult of General Meeting
5th Feb 20149:59 amRNSSch 1-China Private Equity Investment Holdings Ltd
30th Jan 20143:58 pmRNSIrrevocable Undertaking
30th Jan 20147:30 amRNSRestoration - China Private Equity Inv Hldgs Ltd
30th Jan 20147:00 amRNSPosting of Admission Document
31st Dec 20137:30 amRNSSuspension - China Private Equity Inv Hldgs Ltd
31st Dec 20137:00 amRNSAcquisition/Statement Re. Suspension
24th Dec 20137:00 amRNSChange of Adviser
26th Nov 20134:48 pmRNSPatimas Update
20th Nov 201310:08 amRNSDirectorate Change
4th Nov 201311:16 amRNSFurther re disposal
1st Nov 201310:33 amRNSBoard Appointment
24th Sep 201312:22 pmRNSHalf Yearly Report
23rd Sep 201311:02 amRNSInvestment in Asia Bioenergy Technologies Berhad
18th Sep 201310:00 amRNSDisposal
21st Aug 20137:00 amRNSInvestment
26th Jul 201311:01 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.